story of the week
Associations of Disease-Modifying Therapies With COVID-19 Severity in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Neurology 2021 Nov 09;97(19)e1870-e1885, S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, G Edan, Y Moreau, T Spelman, L Geys, T Parciak, C Gautrais, N Lazovski, A Pirmani, A Ardeshirdavanai, L Forsberg, A Glaser, R McBurney, H Schmidt, AB Bergmann, S Braune, A Stahmann, R Middleton, A Salter, RJ Fox, A van der Walt, H Butzkueven, R Alroughani, S Ozakbas, JI Rojas, I van der Mei, N Nag, R Ivanov, G Sciascia do Olival, AE Dias, M Magyari, D Brum, MF Mendes, RN Alonso, RS Nicholas, J Bauer, AS Chertcoff, A Zabalza, G Arrambide, A Fidao, G Comi, L PeetersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.